Skip to main content
Clinical Trials/CTRI/2023/01/048912
CTRI/2023/01/048912
Recruiting
N/A

To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Childs B and C Cirrhosis- A Randomized Controlled Trial

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Cirrhosis with Acute Variceal Bleed
  • 2\.Childâ??s B and C cirrhosis (CTP \<\= 12\)
  • 3\.Patients age between 18 to 75 years

Exclusion Criteria

  • 1\.Gastric variceal bleed
  • 2\.Bleeding related to coagulopathy
  • 3\.Other causes of portal hypertensive
  • 4\.Acute on chronic liver failure
  • 6\.Shock(persistence of hypotension)
  • 7\.Acute kidney injury ( \>1\.5 mg%)
  • 8\.Grade 3 Ascites
  • 9\.Hyponatremia (Na \< 125 mEq/L)
  • 10\.Complete portal vein thrombosis
  • 11\.Hepatocellular carcinoma ( \>3cm lesion)

Outcomes

Primary Outcomes

Not specified

Similar Trials